Glioblastoma exhibits bidirectional adaptation to treatment through JARID2-associated developmental plasticity

Avatar
Poster
Voice is AI-generated
Connected to paperThis paper is a preprint and has not been certified by peer review

Glioblastoma exhibits bidirectional adaptation to treatment through JARID2-associated developmental plasticity

Authors

Thomas, M.; Wang, B.; Craghill, I.; Alghamdi, Y.; Al-Jabri, M.; GK, U.; Finetti, M.; Pollock, S.; Cearns, M. D.; Matthews, L.; Hughes, T. A.; Jenkinson, M. D.; Brodbelt, A. R.; Wade, M.; Jain, A. K.; Bulpitt, A.; Poulter, J.; Stead, L. F.

Abstract

Glioblastoma (GBM) exhibits bidirectional transcriptional reprogramming following standard-of-care (SoC) treatment, yet the direction cannot be predicted from primary tumours. Using independent longitudinal bulk and single-cell datasets, we show that this response is captured by a framework, the JARID2 Binding Site (JBS) axis. Tumours and cells can be positioned along this axis according to expression of JBS genes, with responder subtypes defined by movement along the axis from primary to recurrent states. The JBS axis aligns with established GBM ecosystems and their constituent cell populations, and recurrent tumours polarise towards opposite ends. Changes in tumour microenvironment composition strongly influence this polarisation and drive adaptive transcriptional responses more profoundly than chemoradiation alone. Mechanistically, JBS genes are enriched for promoters marked by persistent bivalent chromatin and neurodevelopmental regulatory programmes. These findings suggest that JARID2-associated Polycomb regulation maintains a reservoir of developmental plasticity that enables treatment-driven ecosystem adaptation and represents a potential therapeutic vulnerability.

Follow Us on

0 comments

Add comment